Edwards Lifesciences Corporation
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2020
Total Assets: $7.24B
Liabilities Breakdown FY2020
Total Liabilities: $2.66B
Asset Breakdown
Total Assets: $7.24B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.18B | 16.3% |
| Accounts Receivable | $514.6M | 7.1% |
| Inventory | $802.3M | 11.1% |
| Property, Plant & Equipment | $1.40B | 19.3% |
| Goodwill | $1.17B | 16.2% |
| Intangible Assets | $331.4M | 4.6% |
| Other Assets | $1.84B | 25.4% |
Liabilities Breakdown
Total Liabilities: $2.66B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $196.5M | 7.4% |
| Long-Term Debt | $595.0M | 22.3% |
| Other Liabilities | $1.87B | 70.3% |